Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer
Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer
Recruiting · NCT04518501 · Registry updated 2024-12-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer | Efficacy and Safety | Recruiting | Phase 1 / Phase 2 | 2024-12-04 | NCT04518501 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xing Xie | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Women's Hospital School Of Medicine Zhejiang University | Zhejiang | China | 1 |